Jump to content

Bijoux71

Members
  • Posts

    3
  • Joined

  • Last visited

  • Country

    United States

Everything posted by Bijoux71

  1. Good afternoon, I hoped to weaken or destroy unexpected (w+) reactivity observed with [2 of 6] cells at LISS-IAT in allo-adsorbed plasma. The CDP (Chloroquin Diphosphate) treated (120 min) cells appeared to have enhanced the plasma reactivity to (2+) at LISS-IAT. Obviously, there is known info about antigens sensitive to CDP treatment but I have not found any mention of blood group antigens enhanced with this chemical. I may try to repeat the CDP treatment with a shorter incubation time, or a 1:3 (cell: CDP) ratio in case it is an overtreatment issue.......Any thoughts or suggestions?
  2. In scenarios like this, questions and possibilities that first come to mind are the following, not in any specific order: 1.) The DAT of the donor unit is extremely relevant. Yes, DATs are not routinely run on all donors however, when IRL testing discovers a discrepant IAT antigen type, Rh or other, a positive DAT is often the culprit. If the discrepant type is at immed spin or direct agglutination, several possibilities come to mind, such as a bacterial contaminated donor unit which may cause spontaneous agglutination, or a medicine that donor takes and is not screened for or donor doesn't give an accurate reply to pre-donation questions, or a donor with a cold agglutinin. 2.) Some previous posts have stated that most current Anti-D reagents will not detect DVI. I feel like that statement is confusing and should be worded to say "most Anti-D reagents will not detect type DVI by direct agglutination, but are able to detect DVI at IAT.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.